47
2023-05-03 20:58:02
Premium
The best of De Telegraaf
Just under 1200 patients with early Alzheimer’s were given the new drug through an IV for 1.5 years.
Ⓒ Foto Getty Images
Amsterdam – The Amsterdam Alzheimer Center, the Amsterdam UMC and the Brain Research Center are enthusiastic about Donanemab, the new drug against Alzheimer’s. Large-scale international research shows that people who are in the early stages of the disease deteriorate less quickly with this drug. “This offers hope. This makes it conceivable that Alzheimer’s disease will one day be curable.”
#Hope #Alzheimers #patient #specialists #enthusiastic #drug #Interior